Department of Pediatrics, Yale University, New Haven, Connecticut.
Maria Fareri Children's Hospital, Westchester, New York.
Shock. 2019 Mar;51(3):298-305. doi: 10.1097/SHK.0000000000001172.
Angiopoietins are postulated diagnostic biomarkers in children and adults with severe sepsis and septic shock. The diagnostic value of angiopoietins in children less than 5 years old has not been established, nor has their effect on permeability in the capillary microvasculature. We aim to determine if levels of angiopoietin-1 or -2 (angpt-1, -2) are diagnostic for severe sepsis/shock in young children and whether they affect the permeability of cultured human dermal microvascular endothelial cells (HDMEC).
Prospective observational study of children < 5 years old. Patients were classified as non-systemic inflammatory response syndrome (SIRS), SIRS/sepsis and severe sepsis/septic shock.
Tertiary care pediatric hospitals.
Critically ill children.
None.
Plasma angpt-1 and -2 levels were measured with enzyme-linked immunoassays. Expression of angpt-2 in endothelial cells was assessed with quantitative polymerase chain reaction. Permeability changes in cultured HDMECs were assessed with transendothelial electrical resistance measurements.
Angpt-1 levels were significantly higher in younger children compared with levels found in previous study of older children across disease severity (all P < 0.001). Angpt-2 was significantly higher in this cohort with severe sepsis/septic shock compared with children without SIRS and SIRS/sepsis (all P < 0.003). Angpt-2/1 ratio was also elevated in children with severe sepsis/septic shock but an order of magnitude less than older children (P < 0.02, P = 0.002). Angpt-1 and -2 did not affect basal HDMEC permeability or modulate leak in isolation or in the presence of tumor necrosis factor (TNF).
Angpt-2 levels and the angpt-2/1 ratio are appropriate diagnostic biomarkers of severe sepsis/septic shock in children less than 5 years old. Neither angpt-1 nor -2 affects basal HDMEC permeability alone or modulates TNF induced capillary leak.
已知在儿童和成人严重脓毒症和脓毒性休克患者中,血管生成素被假定为诊断生物标志物。但是,血管生成素在 5 岁以下儿童中的诊断价值尚未确定,其对毛细血管微血管通透性的影响也尚未确定。本研究旨在确定血管生成素-1 或 -2(angpt-1、-2)水平是否可用于诊断幼儿严重脓毒症/休克,以及它们是否会影响培养的人真皮微血管内皮细胞(HDMEC)的通透性。
对<5 岁的儿童进行前瞻性观察性研究。患者被分为非全身炎症反应综合征(SIRS)、SIRS/败血症和严重脓毒症/脓毒性休克。
三级儿童保健医院。
危重病患儿。
无。
酶联免疫吸附试验测量血浆 angpt-1 和 -2 水平。用定量聚合酶链反应评估内皮细胞中 angpt-2 的表达。用跨内皮电阻测量法评估培养的 HDMEC 通透性的变化。
与以前对不同严重程度儿童的研究相比,年龄较小的儿童的 angpt-1 水平明显更高(所有 P<0.001)。与无 SIRS 和 SIRS/败血症的儿童相比,患有严重脓毒症/脓毒性休克的患儿 angpt-2 水平显著升高(所有 P<0.003)。严重脓毒症/脓毒性休克患儿的 angpt-2/1 比值也升高,但幅度小于年龄较大的儿童(P<0.02,P=0.002)。angpt-1 和 -2 均不影响 HDMEC 的基础通透性,也不能单独或在肿瘤坏死因子(TNF)存在的情况下调节渗漏。
在<5 岁的儿童中,angpt-2 水平和 angpt-2/1 比值是严重脓毒症/脓毒性休克的合适诊断生物标志物。angpt-1 和 -2 均不能单独影响 HDMEC 的基础通透性,也不能调节 TNF 诱导的毛细血管渗漏。